- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...

MOSCOW, July 6, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Morepen Laboratories, one of the leading manufacturers of pharmaceutical products in ...

MUMBAI, Sept 20 (Reuters) - Drug maker Morepen Laboratories Ltd said on Thursday it had lowered the allotment price for a near-15 percent stake sale to a unit of U.S.-based Avenue Capital Group, in ...

DUBAI, DUBAI, UNITED ARAB EMIRATES, August 8, 2025 /EINPresswire.com/ -- Morepen Laboratories Limited, a renowned Indian pharmaceutical giant, has successfully ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Morepen Laboratories Limited (NSEI:MOREPENLAB) trades with a trailing P/E of 42.2x, which is higher than the industry average of 27.2x. While MOREPENLAB might seem like a stock to avoid or sell if you ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Morepen Laboratories Ltd. Annual stock financials by MarketWatch. View the latest MOREPENLAB financial statements, income statements and financial ratios.

India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal Dr. Reddy's Laboratories , one of a handful of Indian drug companies licensed to make a new COVID-19 pill developed by Merck, said ...